These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20711091)

  • 1. [Autoantibodies as predictors of biological therapy for early rheumatoid arthritis].
    da Mota LM; dos Santos Neto LL; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Acta Reumatol Port; 2010; 35(2):156-66. PubMed ID: 20711091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictors of response to biologic therapies in rheumatoid arthritis].
    Chaves Chaparro LM; Salvatierra Ossorio J; Raya Álvarez E
    Reumatol Clin; 2011; 7(2):141-4. PubMed ID: 21794800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
    Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
    Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new serological markers of rheumatoid arthritis].
    Tuchocka-Piotrowska A; Puszczewicz M
    Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.
    van Venrooij WJ; Hazes JM; Visser H
    Neth J Med; 2002 Nov; 60(10):383-8. PubMed ID: 12607587
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion.
    Aho K; Palosuo T; Heliövaara M; Knekt P; Alha P; von Essen R
    J Rheumatol; 2000 Dec; 27(12):2743-6. PubMed ID: 11128658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 13. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
    Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
    Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
    J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.
    Boire G; Cossette P; de Brum-Fernandes AJ; Liang P; Niyonsenga T; Zhou ZJ; Carrier N; Daniel C; Ménard HA
    Arthritis Res Ther; 2005; 7(3):R592-603. PubMed ID: 15899046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms.
    Balsa A; Del Amo J; Blanco F; Caliz R; Silva L; Sanmarti R; Martínez FG; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Collado MD; Andreu JL; Graell E; Simón L; Martínez A; Mulero J
    Rheumatology (Oxford); 2010 Mar; 49(3):458-66. PubMed ID: 20032229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K
    Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.